Acurx pharmaceuticals to discuss 2021 second quarter financial results on august 17, 2021 conference call and provide business update

Staten island, n.y., july 28, 2021 /prnewswire/ -- acurx pharmaceuticals, inc. (nasdaq: acxp) ("acurx" or the "company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today that the company will release its 2021 second quarter financial results on tuesday, august 17, 2021, at 8:30 am et before the u.s. financial markets open.
ACXP Ratings Summary
ACXP Quant Ranking